Facteurs prédictifs de complications céphaliques ischémiques irréversibles au cours de la maladie de Horton : étude prospective sur 178 patients (Q58854438)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11218296%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

[Risk factors for irreversible cerebral ischemia complications from Horton's disease: prospective study of 178 patients] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11218296%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11218296%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Kim Heang Ly

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11218296%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Marie-Odile Jauberteau

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11218296%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

E Liozon

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11218296%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

V Loustaud

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11218296%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

P Soria

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11218296%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

P Y Robert

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11218296%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

F Liozon

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11218296%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

E Vidal

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11218296%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 January 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11218296%20AND%20SRC:MED&resulttype=core&format=json

Revue de Médecine Interne

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11218296%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11218296%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11218296%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

30-41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11218296%20AND%20SRC:MED&resulttype=core&format=json

Ophthalmic complications of giant cell arteritis

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900283-6

7 January 2021

Neurologic aspects of temporal arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900283-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900283-6

1 reference

7 January 2021

Temporal arteritis and polymyalgia rheumatica. Clinical and biopsy findings

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900283-6

7 January 2021

Visual prognosis in giant cell arteritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900283-6

7 January 2021

Neurologic disease in biopsy-proven giant cell (temporal) arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900283-6

7 January 2021

Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900283-6

7 January 2021

Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900283-6

7 January 2021

Giant-cell arteritis, temporal arteritis and polymyalgia rheumatica. A retrospective study of 63 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900283-6

7 January 2021

Clinical features in patients with permanent visual loss due to biopsy-proven giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900283-6

7 January 2021

Risk factors and predictive models of giant cell arteritis in polymyalgia rheumatica

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900283-6

7 January 2021

Risk factors for thrombotic events in giant cell arteritis and polymyalgia rheumatica

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900283-6

7 January 2021

Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900283-6

7 January 2021

Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900283-6

7 January 2021

Ocular manifestations of giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900283-6

7 January 2021

Thrombocytosis and ischaemic complications in giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900283-6

7 January 2021

Platelet-derived growth factor, intimal hyperplasia, and ischemic complications in giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900283-6

7 January 2021

No association between the inflammatory response and the risk of developing irreversible cranial ischemic complications: comment on the article by Cid et al.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900283-6

7 January 2021

[Horton's temporal arteritis. Anatomopathologic study using light microscopy. Apropos of 123 temporal biopsies]

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900283-6

7 January 2021

The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900283-6

7 January 2021

Occult temporal arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900283-6

7 January 2021

Occult giant cell arteritis: ocular manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900283-6

7 January 2021

Temporal arteritis and sensorineural hearing loss

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900283-6

7 January 2021

Giant cell arteritis. Clinical features and involvement of different organs

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900283-6

7 January 2021

[Seasonal incidence of Horton's disease: what to conclude?]

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900283-6

7 January 2021

Masticatory muscle pain: an important indicator of giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900283-6

7 January 2021

Disease pattern in cranial and large-vessel giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900283-6

7 January 2021

Giant cell arteritis with normal sedimentation rate.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900283-6

7 January 2021

Giant cell arteritis. A case with unusual neurologic manifestations and a normal sedimentation rate

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900283-6

7 January 2021

Association between the inflammatory response and the risk of developing irreversible cranial ischemic complications: comment on the article by Cid et al and the letter by Nesher and Sonnenblick

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900283-6

7 January 2021

Giant cell arteritis: validity and reliability of various diagnostic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900283-6

7 January 2021

Giant cell vasculitis is a T cell-dependent disease

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900283-6

7 January 2021

Disease patterns and tissue cytokine profiles in giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900283-6

7 January 2021

IFN-gamma in combination with IL-3 accelerates platelet recovery in mice with 5-fluorouracil-induced marrow aplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900283-6

7 January 2021

Interferon-gamma and human megakaryopoiesis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900283-6

7 January 2021

Megakaryocytic differentiation of HIMeg-1 cells induced by interferon gamma and tumour necrosis factor alpha but not by thrombopoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900283-6

7 January 2021

Low flow enhances platelet activation after acute experimental arterial injury

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900283-6

7 January 2021

Thrombocytosis and giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900283-6

7 January 2021

10.1016/S0248-8663(00)00283-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11218296%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference